NPs Basic Information

Name
terrtryptop A
Molecular Formula C16H19N3O2
IUPAC Name*
2-hydroxyimino-3-[7-(3-methylbut-2-enyl)-1H-indol-3-yl]propanamide
SMILES
CC(C)=CCc1cccc2c(CC(=NO)C(N)=O)c[nH]c12
InChI
InChI=1S/C16H19N3O2/c1-10(2)6-7-11-4-3-5-13-12(9-18-15(11)13)8-14(19-21)16(17)20/h3-6,9,18,21H,7-8H2,1-2H3,(H2,17,20)/b19-14+
InChIKey
WIABFPOGRRFJPJ-XMHGGMMESA-N
Synonyms
NA
CAS NA
PubChem CID NA
ChEMBL ID NA
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Indoles and derivatives
        • Subclass: Tryptamines and derivativ
          • Direct Parent: Tryptamines and derivativ

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 285.35 ALogp: 2.5
HBD: 3 HBA: 3
Rotatable Bonds: 5 Lipinski's rule of five: Accepted
Polar Surface Area: 91.5 Aromatic Rings: 2
Heavy Atoms: 21 QED Weighted: 0.34

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.825 MDCK Permeability: 0.00000826
Pgp-inhibitor: 0.014 Pgp-substrate: 0.145
Human Intestinal Absorption (HIA): 0.008 20% Bioavailability (F20%): 0.924
30% Bioavailability (F30%): 0.304

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.961 Plasma Protein Binding (PPB): 97.82%
Volume Distribution (VD): 0.879 Fu: 2.05%

ADMET: Metabolism

CYP1A2-inhibitor: 0.914 CYP1A2-substrate: 0.168
CYP2C19-inhibitor: 0.926 CYP2C19-substrate: 0.059
CYP2C9-inhibitor: 0.707 CYP2C9-substrate: 0.877
CYP2D6-inhibitor: 0.722 CYP2D6-substrate: 0.674
CYP3A4-inhibitor: 0.428 CYP3A4-substrate: 0.171

ADMET: Excretion

Clearance (CL): 5.902 Half-life (T1/2): 0.419

ADMET: Toxicity

hERG Blockers: 0.056 Human Hepatotoxicity (H-HT): 0.876
Drug-inuced Liver Injury (DILI): 0.945 AMES Toxicity: 0.461
Rat Oral Acute Toxicity: 0.79 Maximum Recommended Daily Dose: 0.598
Skin Sensitization: 0.171 Carcinogencity: 0.13
Eye Corrosion: 0.003 Eye Irritation: 0.031
Respiratory Toxicity: 0.264
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001987 0.488 D05EJG 0.299
ENC001366 0.420 D0AN7B 0.293
ENC002096 0.377 D0N1WU 0.272
ENC003357 0.375 D02IHW 0.247
ENC004349 0.365 D0U1OM 0.242
ENC001090 0.361 D0WD8M 0.238
ENC004987 0.361 D00XWD 0.235
ENC003358 0.346 D0O2YE 0.235
ENC000043 0.338 D0Z6UC 0.228
ENC004988 0.333 D0BV3J 0.227
*Note: the compound similarity was calculated by RDKIT.